-
Most Popular
Search Results
176 results for yuii
OCGN Stock: Why Red-Hot Ocugen Is on the Move Today
OCGN stock is on the move today after receiving orphan drug status for its OCU400 from the European Commission. Here’s what to know.
MDGS Stock: 15 Things to Know About Medigus as the Penny Stock Soars
Medigus (MDGS) stock has caught the eye of investors on Friday with shares heading higher on news of pre-clinical trials doing well.
SENS Stock: Why Reddit Is Betting Big on a Short Squeeze for Senseonics Today
SENS stock is gaining ground as a potential short-squeeze play on r/WallStreetBets today. Here’s what you need to know about Senseonics.
ARPO Stock: 12 Things to Know About Aerpio Pharma as Analyst Upgrade Sends Shares Soaring
Aerpio Pharmaceuticals (ARPO) stock is flying high on Thursday after an analyst upgrade gave the company’s shares a boost today.
Why Are Cannabis Stocks Down Today?
Cannabis stocks aren’t doing so hot on Wednesday as it appears banking legislation is unlikely to make it through Congress this year.
Why Is Harpoon Therapeutics (HARP) Stock Up 100%+ Today?
Harpoon Therapeutics (HARP) stock is taking off on Monday following the release of updated results from its myeloma drug candidate.
Why Is VolitionRX (VNRX) Stock Down 17% Today?
VolitionRX (VNRX) stock is taking a beating on Friday after the company revealed a proposed public offering for its shares.
MNKD Stock: The Disappointing FDA News That Has MannKind Shares Diving Today
MannKind (MNKD) stock is taking a beating on Monday after releasing an update to investors concerning news from the FDA for Tyvaso DPI.
3 High-Growth Stocks with Fat Dividends
Scouring the market for stocks that offer a trifecta of high growth, hefty dividends and bargain-basement prices yields some compelling plays.
3 Food Stocks for Smart Investors to Eat Up Now
Even if consumer spending is dropping significantly, these food stocks are safe buys — everyone needs to eat!
Why Is Viveve Medical (VIVE) Stock Down 69% Today?
Viveve Medical (VIVE) stock is falling hard on Tuesday after releasing poor results from the company’s latest clinical trial.
Alzheimer’s News: Why Is Drugmaker Longeveron (LGVN) Soaring Today?
Longeveron (LGVN) stock is taking off on Thursday after the drugmaker published news related to an Alzheimer’s treatment.
Why Is Hoth Therapeutics (HOTH) Stock Skyrocketing 110% Today?
Hoth Therapeutics (HOTH) stock is rising higher on Monday after the biopharmaceutical company provided an update on HT-KIT.
GRTX Stock Alert: The Surprising News That Has Galera Therapeutics Going Gangbusters Today
Galera Therapeutics (GRTX) stock is rocketing higher on Tuesday after the company revealed corrected results from a Phase 3 clinical trial.
BFRI Stock: The News That Has Biofrontera Shares Bounding Higher Today
Biofrontera (BFRI) stock is getting a boost on Thursday thanks to an update from the United States Patent and Trademark Office.
PTE Stock Soars 70% Following PolarityTE’s New FDA Designation
PolarityTE (PTE) stock is rocketing higher on Friday thanks to positive news from the U.S. Food and Drug Administration (FDA).
Why Is Indaptus Therapeutics (INDP) Stock Up 20% Today?
Indaptus Therapeutics (INDP) stock is soaring higher on Thursday following an update from the U.S. Food and Drug Administration (FDA).
IMMX Stock Alert: The Massive FDA Win That Has Immix Biopharma Blasting Higher Today
Immix Biopharma (IMMX) stock is taking off Monday thanks to a Rare Pediatric Disease designation from the U.S. Food and Drug Administration.
RNAZ Stock Alert: The Breast Cancer Study News Sending TransCode Therapeutics Soaring Today
TransCode Therapeutics (RNAZ) stock is rocketing higher on Thursday as investors react to positive news from a breast cancer study.
KTTA Stock: The Depression Nasal Spray News That Has Pasithea Therapeutics Investors Ecstatic Today
Pasithea Therapeutics (KTTA) stock is rocketing higher on Tuesday after adding esketamine nasal spray to its U.K. offerings.
APRE Stock: The Big Leukemia Study News That Has Aprea Therapeutics Skyrocketing Today
Aprea Therapeutics (APRE) stock is seeing major gains on Wednesday after revealing results from a recent Phase 1/2 trial.
SPRO Stock Alert: 9 Things to Know as Spero Therapeutics Plunges 50%
Spero Therapeutics (SPRO) stock is taking a beating on Tuesday after the biotech company revealed a change in strategic direction.
ENLV Stock: Why Enlivex Is Soaring 70% Today
Enlivex just announced that it will launch Phase 2 trials for a plasma-based coronavirus treatment, and ENLV stock is soaring in response.
6 – 8 of 176 results
